| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Myasthenia gravis | 406 | 39 | |
| Hypogammaglobulinemia | 295 | 56 | |
| Chronic inflammatory demyelinating polyneuropathy | 256 | 35 | |
| Common variable immune deficiency | 208 | 36 | |
| Multifocal motor neuropathy | 103 | 22 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Headaches | 86 | |
| Nausea | 27 | |
| Fatigue | 26 | |
| Migraine headaches | 21 | |
| Fever/chills | 9 | |
| Aseptic meningitis | 7 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 35 | |
| Moderate | 74 | |
| Mild | 134 | |
| None | 111 |
Member evaluations
sarahbellum
evaluated on Sep 21, 2013
- Perceived effectiveness for multiple sclerosis: Major
- Side effects: None
cpt_c_pike
evaluated on Jun 28, 2013
- Perceived effectiveness for amyotrophic lateral sclerosis: Slight
- Side effects: None
nirvis
evaluated on Jun 15, 2012
- Perceived effectiveness for multifocal motor neuropathy: None
- Side effects: Mild